To view the PDF file, sign up for a MySharenet subscription.

AFROCENTRIC INVESTMENT CORP LIMITED - Changes to the board

Release Date: 08/12/2015 17:30
Code(s): ACT     PDF:  
Wrap Text
Changes to the board

AFROCENTRIC INVESTMENT CORPORATION LIMITED
(Incorporated in the Republic of South Africa)
(Registration number: 1988/000570/06)
JSE Code: ACT
ISIN: ZAE000078416
(“AfroCentric” or “the Company” or “the Group”)


CHANGE OF ROLE OF A DIRECTOR AND NEW NON-EXECUTIVE DIRECTOR
APPOINTMENT

In compliance with section 3.59 of the JSE Limited Listings Requirements, the
AfroCentric board of directors (“the Board”) wishes to announce the following
changes.

CHANGE OF ROLE OF DIRECTOR

Given the Company’s recent corporate actions and other changes to the Group’s
corporate and operational structures, the Board have resolved to appoint a new Chief
Executive Officer (“CEO”). Accordingly a change of role will occur in that Mr Dewald
Dempers will step down as CEO with immediate effect.

Mr. Dempers will however continue to act as an Executive Director on the Board
responsible for new growth opportunities, including inter alia, the promotion of
business expected to arise through the Company’s recent developments and
corporate actions.

The role of CEO will temporarily be filled by Non Executive Chairman, Dr. Anna
Mokgokong while the company finalises the appointment of the new CEO.

Shareholders are also advised that post a recent review of their classification on the
Board, both Mr J.M.Kahn and Mr M.I. Sacks, previously Non-Executive Directors, are
now classified as Independent Non-Executive Directors. Mr G.L. Napier will continue
to serve as the Lead Independent Director.

APPOINTMENT OF NON-EXECUTIVE DIRECTOR

The Board is also pleased to announce the appointment of Dr Nkateko David Munisi
as a Non-Executive Director of the Board with effect from 7 December 2015.

Nkateko is a qualified and practicing medical doctor with extensive experience in the
industry having served on numerous committees, boards and panels throughout his
career. He is amongst other things currently the chairman of the medical panel at the
Eskom Pension and Provident Fund and the Public Investment Corporation’s
representative in the healthcare infrastructure fund, RH Managers where he currently
serves as chairman of the advisory committee.
Nkateko is a director and the current chairman of Golden Pond Trading 175 (Pty)
Limited, a joint venture company between SGH and Community Healthcare Holdings
(Pty) Limited who are material shareholders in AfroCentric.

The Board welcomes Nkateko and wishes him well on his new appointment.

Johannesburg
8 December 2015

Sponsor
Sasfin Capital (a division of Sasfin Bank Limited)

Date: 08/12/2015 05:30:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.

Share This Story